142 related articles for article (PubMed ID: 31097447)
1. Dietary iron restriction leads to a reduction in hepatic fibrosis in a rat model of non-alcoholic steatohepatitis.
Abe N; Tsuchida T; Yasuda SI; Oka K
Biol Open; 2019 May; 8(5):. PubMed ID: 31097447
[TBL] [Abstract][Full Text] [Related]
2. Attenuation of the Hepatoprotective Effects of Ileal Apical Sodium Dependent Bile Acid Transporter (ASBT) Inhibition in Choline-Deficient L-Amino Acid-Defined (CDAA) Diet-Fed Mice.
Rao A; van de Peppel IP; Gumber S; Karpen SJ; Dawson PA
Front Med (Lausanne); 2020; 7():60. PubMed ID: 32158763
[TBL] [Abstract][Full Text] [Related]
3. Persistent fibrosis in the liver of choline-deficient and iron-supplemented L-amino acid-defined diet-induced nonalcoholic steatohepatitis rat due to continuing oxidative stress after choline supplementation.
Takeuchi-Yorimoto A; Noto T; Yamada A; Miyamae Y; Oishi Y; Matsumoto M
Toxicol Appl Pharmacol; 2013 May; 268(3):264-77. PubMed ID: 23481610
[TBL] [Abstract][Full Text] [Related]
4. Influence of nicotine on choline-deficient, L-amino acid-defined diet-induced non-alcoholic steatohepatitis in rats.
Kanamori H; Nakade Y; Yamauchi T; Sakamoto K; Inoue T; Yamamoto T; Kobayashi Y; Ishii N; Ohashi T; Ito K; Sumida Y; Nakao H; Fukuzawa Y; Yoneda M
PLoS One; 2017; 12(6):e0180475. PubMed ID: 28662136
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of hyaluronan synthesis by 4-methylumbelliferone ameliorates non-alcoholic steatohepatitis in choline-deficient L-amino acid-defined diet-induced murine model.
Yang YM; Wang Z; Matsuda M; Seki E
Arch Pharm Res; 2021 Feb; 44(2):230-240. PubMed ID: 33486695
[TBL] [Abstract][Full Text] [Related]
6. Transgenic expression of human neutrophil peptide-1 enhances hepatic fibrosis in mice fed a choline-deficient, L-amino acid-defined diet.
Ibusuki R; Uto H; Arima S; Mawatari S; Setoguchi Y; Iwashita Y; Hashimoto S; Maeda T; Tanoue S; Kanmura S; Oketani M; Ido A; Tsubouchi H
Liver Int; 2013 Nov; 33(10):1549-56. PubMed ID: 23682724
[TBL] [Abstract][Full Text] [Related]
7. The peroxisome proliferator-activated receptor-gamma agonist, pioglitazone, inhibits fat accumulation and fibrosis in the livers of rats fed a choline-deficient, l-amino acid-defined diet.
Uto H; Nakanishi C; Ido A; Hasuike S; Kusumoto K; Abe H; Numata M; Nagata K; Hayashi K; Tsubouchi H
Hepatol Res; 2005 Aug; 32(4):235-42. PubMed ID: 16085455
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of Hepcidin Alleviates Steatohepatitis and Fibrosis in a Diet-induced Nonalcoholic Steatohepatitis.
Chen H; Zhao W; Yan X; Huang T; Yang A
J Clin Transl Hepatol; 2022 Aug; 10(4):577-588. PubMed ID: 36062292
[TBL] [Abstract][Full Text] [Related]
9. C-type natriuretic peptide (CNP) in endothelial cells attenuates hepatic fibrosis and inflammation in non-alcoholic steatohepatitis.
Bae CR; Hino J; Hosoda H; Miyazato M; Kangawa K
Life Sci; 2018 Sep; 209():349-356. PubMed ID: 30114411
[TBL] [Abstract][Full Text] [Related]
10. Ipragliflozin, an SGLT2 inhibitor, exhibits a prophylactic effect on hepatic steatosis and fibrosis induced by choline-deficient l-amino acid-defined diet in rats.
Hayashizaki-Someya Y; Kurosaki E; Takasu T; Mitori H; Yamazaki S; Koide K; Takakura S
Eur J Pharmacol; 2015 May; 754():19-24. PubMed ID: 25701721
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory effect of dietary iron deficiency on inductions of putative preneoplastic lesions as well as 8-hydroxydeoxyguanosine in DNA and lipid peroxidation in the livers of rats caused by exposure to a choline-deficient L-amino acid defined diet.
Yoshiji H; Nakae D; Mizumoto Y; Horiguchi K; Tamura K; Denda A; Tsujii T; Konishi Y
Carcinogenesis; 1992 Jul; 13(7):1227-33. PubMed ID: 1638691
[TBL] [Abstract][Full Text] [Related]
12. Interventional Potential of Recombinant Feline Hepatocyte Growth Factor in a Mouse Model of Non-alcoholic Steatohepatitis.
Yang YM; Fukui M; Wang Z; Miao F; Karriker MJ; Seki E
Front Endocrinol (Lausanne); 2018; 9():378. PubMed ID: 30083132
[No Abstract] [Full Text] [Related]
13. Impact of artificial sunlight therapy on the progress of non-alcoholic fatty liver disease in rats.
Nakano T; Cheng YF; Lai CY; Hsu LW; Chang YC; Deng JY; Huang YZ; Honda H; Chen KD; Wang CC; Chiu KW; Jawan B; Eng HL; Goto S; Chen CL
J Hepatol; 2011 Aug; 55(2):415-25. PubMed ID: 21184788
[TBL] [Abstract][Full Text] [Related]
14. Beneficial effects of mineralocorticoid receptor blockade in experimental non-alcoholic steatohepatitis.
Pizarro M; Solís N; Quintero P; Barrera F; Cabrera D; Rojas-de Santiago P; Arab JP; Padilla O; Roa JC; Moshage H; Wree A; Inzaugarat E; Feldstein AE; Fardella CE; Baudrand R; Riquelme A; Arrese M
Liver Int; 2015 Sep; 35(9):2129-38. PubMed ID: 25646700
[TBL] [Abstract][Full Text] [Related]
15. Fluvastatin attenuates hepatic steatosis-induced fibrogenesis in rats through inhibiting paracrine effect of hepatocyte on hepatic stellate cells.
Chong LW; Hsu YC; Lee TF; Lin Y; Chiu YT; Yang KC; Wu JC; Huang YT
BMC Gastroenterol; 2015 Feb; 15():22. PubMed ID: 25886887
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-21 is associated with fibrosis in a rat model of nonalcoholic steatohepatitis and serves as a plasma biomarker for fibrotic liver disease.
Takeuchi-Yorimoto A; Yamaura Y; Kanki M; Ide T; Nakata A; Noto T; Matsumoto M
Toxicol Lett; 2016 Sep; 258():159-167. PubMed ID: 27320964
[TBL] [Abstract][Full Text] [Related]
17. Lansoprazole prevents the progression of liver fibrosis in non-alcoholic steatohepatitis model rats.
Nishi T; Yamamoto Y; Yamagishi N; Iguchi M; Tamai H; Ito T; Tsuruo Y; Ichinose M; Kitano M; Ueyama T
J Pharm Pharmacol; 2018 Mar; 70(3):383-392. PubMed ID: 29355950
[TBL] [Abstract][Full Text] [Related]
18. Hypertension exacerbates liver injury and hepatic fibrosis induced by a choline-deficient L-amino acid-defined diet in rats.
Arima S; Uto H; Ibusuki R; Kumamoto R; Tanoue S; Mawatari S; Oda K; Numata M; Fujita H; Oketani M; Ido A; Tsubouchi H
Int J Mol Med; 2014 Jan; 33(1):68-76. PubMed ID: 24190226
[TBL] [Abstract][Full Text] [Related]
19. TRIF Differentially Regulates Hepatic Steatosis and Inflammation/Fibrosis in Mice.
Yang L; Miura K; Zhang B; Matsushita H; Yang YM; Liang S; Song J; Roh YS; Seki E
Cell Mol Gastroenterol Hepatol; 2017 May; 3(3):469-483. PubMed ID: 28462384
[TBL] [Abstract][Full Text] [Related]
20. Pioglitazone prevents hepatic steatosis, fibrosis, and enzyme-altered lesions in rat liver cirrhosis induced by a choline-deficient L-amino acid-defined diet.
Kawaguchi K; Sakaida I; Tsuchiya M; Omori K; Takami T; Okita K
Biochem Biophys Res Commun; 2004 Feb; 315(1):187-95. PubMed ID: 15013444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
